The ADS1299IPAGR is a low-noise, eight-channel, 24-bit delta-sigma (ΔΣ) analog-to-digital converter designed specifically for biopotential measurements, including electroencephalography (EEG) and electrocardiography (ECG). Unlike general-purpose ADCs that require extensive external signal conditioning, the ADS1299IPAGR integrates programmable gain amplifiers (PGAs), a bias drive amplifier, lead-off detection circuitry, and an onboard oscillator into a single 64-pin TQFP package. This level of integration enables the construction of scalable medical instrumentation with reduced size, power consumption, and overall system cost.

The ADS1299IPAGR is organized around a per-channel signal chain that begins with a flexible input multiplexer. Each of the eight channels can be independently connected to internally generated test signals, temperature measurements, or lead-off detection sources. This multiplexer flexibility allows the device to support both referential and sequential montage configurations without external switching networks.

Following the multiplexer, each channel feeds a low-noise PGA with programmable gain settings of 1, 2, 4, 6, 8, 12, or 24. The amplified signal is then digitized by a simultaneous-sampling 24-bit ΔΣ ADC. The simultaneous-sampling architecture is critical for multichannel biopotential applications, as it preserves the phase relationships between channels—a requirement for accurate spatial filtering and source localization in EEG.

The device incorporates a built-in bias drive amplifier whose output can be derived from any configuration of input channels. This allows the implementation of a driven-right-leg or common-mode feedback scheme without additional active components. Optional SRB (stimulus reference bus) pins route a common signal to multiple inputs for referential montage configurations.

The table below presents the key performance parameters of the ADS1299IPAGR.

The combination of 1 μV_PP input-referred noise and –110 dB CMRR places the ADS1299IPAGR in a class of converters suitable for detecting signals in the microvolt range, which is the domain of cortical EEG and high-resolution ECG.

The ADS1299IPAGR is not merely an ADC; it is a complete biopotential acquisition subsystem. Several integrated functions merit particular attention.

Lead-Off Detection. The device implements lead-off detection internally using an excitation current sink or source. When an electrode disconnects from the patient, the resulting change in the input bias path is detected and reported. This function is essential for patient safety monitoring in clinical EEG and ECG systems.

Flexible Power Management. A flexible power-down and standby mode allows the device to reduce current consumption between measurement cycles, an important consideration for battery-powered or ambulatory monitoring equipment.

Cascading Capability. Multiple ADS1299-4, ADS1299-6, or ADS1299 devices can be cascaded in a daisy-chain configuration for high-channel-count systems. This scalability supports applications ranging from 8-channel research EEG headsets to 64-channel or 128-channel clinical systems.

Pin Compatibility. The ADS1299IPAGR is pin-compatible with the ADS129x family, providing a migration path for designers who may need to scale channel count or performance within the same board footprint.

The primary application domain of the ADS1299IPAGR is extracranial EEG and ECG measurement. Within EEG, the device supports both research-grade systems requiring high channel counts and clinical systems where patient safety and artifact rejection are paramount. The lead-off detection and bias drive functions directly address the electrical safety requirements of patient-connected medical devices.

Beyond EEG and ECG, the device is applicable to other biopotential measurements where the signal of interest is in the microvolt range and the source impedance is moderate to high. These include electromyography (EMG) for muscle activity monitoring and evoked potential systems where a stimulus is applied and the neural response is recorded.

The ADS1299IPAGR addresses a specific and demanding niche: the acquisition of microvolt-level biopotential signals in multichannel configurations. Its value proposition lies not in any single specification, but in the integration of low-noise analog front-end circuitry, simultaneous-sampling conversion, and patient-safety-oriented features into a single package. For designers of EEG and ECG instrumentation, the device offers a path to reduced component count, smaller form factor, and lower power consumption without compromising signal fidelity.